Genetic Testing Market

  • Published on 2025-11-09
  • Report Code: 824
  • 174 pages
Genetic Testing Market

Genetic Testing Market Size & Share to Boom at Double-Digit CAGR During Forecast Year 2020-2030

Table Of Content

Contents          

  1. Executive Summary
  2. Global Genetic Testing Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Genetic testing market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Genetic Testing market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Genetic Testing Market: Market Segmentation
    1. By Regions
      1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Asia-Pacific: (China, India, Japan, South Korea, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Middle East and Africa: (Saudi Arabia, South Africa, UAE and rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Latin America (Brazil, Mexico and Argentina, Rest of South America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Types of Testing: Market Share (2020-2030F)
      1. Newborn Screening, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Diagnostic testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Carrier testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Prenatal testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Forensic testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      6. Predictive and presymtomatic testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      7. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By Methods: Market Share (2020-2030F)
      1. Molecular Genetic Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Chromosomal Genetic Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Biochemical Genetic Testing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    4. By Testing Sample: Market Share (2020-2030F)
      1. Blood, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Saliva, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Hair, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Tumors, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    5. By Industry: Market Share (2020-2030F)
      1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Nursing homes, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Blood Banks, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

Company Profile

  1. Abbott Laboratories
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  2. Bio-Rad Laboratories Inc.
  3. Myriad Genetics, Inc. (Myriad RBM, Inc.)
  4. Danaher Corporation (Cepheid)
  5. F. Hoffmann-La Roche AG
  6. Eurofins Scientific
  7. Illumina Inc.
  8. Thermo Fisher Scientific
  9. Danaher Corporation (Cepheid Inc)
  10. RainDance Technologies Inc.

Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients